BACK TO TOP
KSE100
170,765.22
266.28
(0.16%)
KSE100PR
51,483.72
80.28
(0.16%)
ALLSHR
103,241.05
137.96
(0.13%)
KSE30
50,813.89
74.20
(0.15%)
KMI30
244,391.30
186.14
(0.08%)
BKTI
47,274.31
141.41
(0.30%)
OGTI
35,009.43
46.87
(0.13%)
KMIALLSHR
66,928.26
55.24
(0.08%)
PSXDIV20
77,992.00
238.08
(0.31%)
UPP9
60,824.99
27.95
(0.05%)
NITPGI
45,312.56
34.95
(0.08%)
NBPPGI
48,711.08
51.31
(0.11%)
MZNPI
30,508.45
7.49
(0.02%)
JSMFI
43,460.24
118.32
(0.27%)
ACI
22,103.89
89.38
(0.41%)
JSGBKTI
71,590.63
242.68
(0.34%)
HBLTTI
19,106.07
24-09-2026
3.61
(0.02%)
MII30
22,080.00
14.26
(0.06%)
Ferozsons Laboratories Limited
PHARMACEUTICALS
Rs.322.84
-7.36
(-2.23%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Sep 25, 2026 4:48 PM
REG
DFC
CSF
ODL
Open
343.80
High
345.00
Low
316.50
Volume
28,777
CIRCUIT BREAKER
297.18 — 363.22
DAY RANGE
316.50 — 345.00
52-WEEK RANGE ^
293.01 — 475.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
330.20
VAR
18.00
HAIRCUT
22.50
P/E Ratio (TTM) **
21.87
1-Year Change * ^
-19.66%
YTD Change * ^
-14.08%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was converted into a public limited company on 08 September 1960. The Company is primarily engaged in the imports, manufacture and sale of pharmaceutical products and medical devices.

KEY PEOPLE
Osman Khalid WaheedCEO
Amna Piracha KhanChairperson
Syed Ghausuddin SaifCompany Secretary
ADDRESS

Ferozsons Laboratories Limited 197-A, The Mall Rawalpindi, Pakistan.

WEBSITE

www.ferozsons-labs.com

REGISTRAR

CorpTec Associates (Pvt.) Limited, 503-E, Johar Town, Lahore

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
14,033,548.42
Shares
43,469,051
Free Float
17,387,621
Free Float
40.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2026Transmission of Quarterly Report for the Period Ended 31-03-2026 View   PDF
Apr 29, 2026Financial Results for the Quarter Ended 31-03-2026 View   PDF
Feb 27, 2026Transmission of Quarterly Financial Statements for the Period Ended 31-12-2025 View   PDF
Feb 26, 2026Financial Results for the Quarter Ended 31-12-2025 View   PDF
Oct 30, 2025Transmission of Quarterly Financial Statements for the Period Ended 30-09-2025 View   PDF
DateTitleDocument
Sep 22, 2026Board Meeting View   
Jul 7, 2026Board Meeting Other Than Financial Results View   
Jun 12, 2026Notice of Extraordinary General Meeting View   PDF
Jun 11, 2026Notice of Extraordinary General Meeting prior to publication View   PDF
Apr 22, 2026Board Meeting View   
DateTitleDocument
Sep 17, 2026Material Information View   PDF
Jul 15, 2026Approval of Annual Budget for FY 2026-27 View   
Jul 15, 2026Appointment of Chairperson and Chief Executive Officer View   
Jul 3, 2026Certified True Copy of Resolution passed by the Shareholders in EOGM of the Company held on July 03, 2026 View   PDF
Jun 24, 2026Election of Directors View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,857,96712,711,7149,893,3917,806,414
Profit after Taxation528,243400,054189,042514,149
EPS12.159.204.3511.83
Q3 2026Q2 2026Q1 2026Q3 2025
Sales3,659,6864,405,7813,883,2523,778,689
Profit after Taxation150,250171,195182,420138,117
EPS3.463.934.203.18
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)41.2738.8838.6345.06
Net Profit Margin (%)3.813.151.916.59
EPS Growth (%)32.07111.49(63.23)(40.91)
PEG1.000.24(0.50)(0.56)

Payouts

Financial Reports